Principal Financial Group
ANAC

Principal Financial Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Principal Financial Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-71,097
Closed -$3.8M – 2278
2016
Q1 		$3.8M Buy
71,097
+11,892
+20% +$878K 0.01% 1480
2015
Q4 		$6.69M Buy
59,205
+9,726
+20% +$1.07M 0.01% 1205
2015
Q3 		$5.82M Buy
49,479
+42,414
+600% +$5.54M 0.01% 1275
2015
Q2 		$547K Sell
7,065
-247
-3% -$16.2K ﹤0.01% 1868
2015
Q1 		$424K Buy
7,312
+596
+9% +$25.3K ﹤0.01% 1858
2014
Q4 		$217K Sell
6,716
-4,086
-38% -$123K ﹤0.01% 2019
2014
Q3 		$264K Hold
10,802
– – ﹤0.01% 1963
2014
Q2 		$192K Sell
10,802
-1,915
-15% -$30.8K ﹤0.01% 2100
2014
Q1 		$254K Sell
12,717
-121
-0.9% -$2.35K ﹤0.01% 2053
2013
Q4 		$215K Buy
+12,838
New +$178K ﹤0.01% 2126

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Principal Financial Group's ANAC Position: Q2 2016 in Review

Principal Financial Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 71,097 shares — an estimated $3.8M sold.

Principal Financial Group first reported a position in ANAC in Q4 2013 and held it in 10 quarters. The position peaked at $6.69M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Principal Financial Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Principal Financial Group sold 71,097 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $3.8M.
  • Principal Financial Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 10 quarters.
  • Principal Financial Group's ANACOR PHARMACEUTICALS INC COM position peaked at $6.69M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Principal Financial Group's 13F filing for Q2 2016, filed 9 Aug 2016.